Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gene editing of monogenic disorders in human hematopoietic stem cells—correction of X-linked agammaglobulinemia (XLA)

Gene editing of monogenic disorders in human hematopoietic stem cells—correction of X-linked agammaglobulinemia (XLA)

US Patent 12492411 · Granted Dec 9, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Stapler2025
Self-inactivating lentiviral vector comprising a FOXP3 expression cassette2024
Self-inactivating lentiviral vector comprising a FOXP3 expression cassette2024
Optimized lentiviral vector for stem cell gene therapy of hemoglobinopathies2024
Optimized lentiviral vector for stem cell gene therapy of hemoglobinopathies2024
Fastener2020
Method for treating adenosine deaminase severe combined imunodeficiency2020
Cable clip2018
Expandable tip delivery system and method2012
Roof boundary clip2009
Roof boundary clip2007
Gene therapy by administration of genetically engineered CD34+ cells obtained fr2006